(Q38635415)

5 September 2017

An Overview of Organ-Specific Autoimmune Diseases Including Immunotherapy (English)

1 reference

5 September 2017

1 reference

Lucy D Mastrandrea

1

1 reference

5 September 2017

1 November 2015

1 reference

Immunological Investigations

5 September 2017

1 reference

5 September 2017

44

1 reference

5 September 2017

8

1 reference

5 September 2017

803-816

1 reference

An autoimmune disease, APECED, caused by mutations in a novel gene featuring two PHD-type zinc-finger domains

5 September 2017

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2015.1099409

Efficacy and safety of low-dose otelixizumab anti-CD3 monoclonal antibody in preserving C-peptide secretion in adolescent type 1 diabetes: DEFEND-2, a randomized, placebo-controlled, double-blind, multi-centre study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2015.1099409

Cytokines and diabetes: the final step? Involvement of TNF-alpha in both type I and II diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2015.1099409

The pathogenesis and natural history of type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2015.1099409

Self-antigen-driven activation induces instability of regulatory T cells during an inflammatory autoimmune response

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2015.1099409

Red blood cell destruction in autoimmune hemolytic anemia: role of complement and potential new targets for therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2015.1099409

21 January 2018

Mechanisms of tolerance.

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2015.1099409

Cellular immunity and immunopathology in autoimmune Addison's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2015.1099409

Recent insights in the epidemiology of autoimmune diseases: improved prevalence estimates and understanding of clustering of diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2015.1099409

Prevalence of type 1 and type 2 diabetes among children and adolescents from 2001 to 2009.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2015.1099409

Prevention of Rheumatic Fever and Diagnosis and Treatment of Acute Streptococcal Pharyngitis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2015.1099409

Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2015.1099409

Effects of abatacept in patients with methotrexate-resistant active rheumatoid arthritis: a randomized trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2015.1099409

Life-threatening histoplasmosis complicating immunotherapy with tumor necrosis factor alpha antagonists infliximab and etanercept

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2015.1099409

Thyroid associated orbitopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2015.1099409

Etanercept treatment in children with new-onset type 1 diabetes: pilot randomized, placebo-controlled, double-blind study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2015.1099409

The incidence and prevalence of thyroid autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2015.1099409

Prevention and treatment of systemic glucocorticoid side effects

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2015.1099409

Regulatory T cells and mechanisms of immune system control

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2015.1099409

Pancreatic islet autoantibodies as predictors of type 1 diabetes in the Diabetes Prevention Trial-Type 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2015.1099409

Clinical response to alefacept: results of a phase 3 study of intramuscular administration of alefacept in patients with chronic plaque psoriasis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2015.1099409

Prevalence of diabetes in U.S. youth in 2009: the SEARCH for diabetes in youth study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2015.1099409

Targeting of memory T cells with alefacept in new-onset type 1 diabetes (T1DAL study): 12 month results of a randomised, double-blind, placebo-controlled phase 2 trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2015.1099409

Efficacy of B-cell targeted therapy with rituximab in patients with active moderate to severe Graves' orbitopathy: a randomized controlled study.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2015.1099409

Stopping type 1 diabetes: attempts to prevent or cure type 1 diabetes in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2015.1099409

Induction of GAD65-specific regulatory T-cells inhibits ongoing autoimmune diabetes in nonobese diabetic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2015.1099409

The role of innate immune responses in autoimmune disease development

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2015.1099409

Antigen-based therapy with glutamic acid decarboxylase (GAD) vaccine in patients with recent-onset type 1 diabetes: a randomised double-blind trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2015.1099409

Preventing and treating biologic-associated opportunistic infections.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2015.1099409

B-lymphocyte contributions to human autoimmune disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2015.1099409

Comparison of double filtration plasmapheresis with immunoadsorption therapy in patients with anti-glomerular basement membrane nephritis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2015.1099409

10.3109/08820139.2015.1099409

21 January 2018

Identifiers

DOI

1 reference

5 September 2017

1 reference

PubMed ID

26575465